Supraventricular Tachycardia, Arrhythmia, Lung Tuberculosis, Adverse Effect
Background: Arrhythmia in tuberculosis is a rare and life-threatening condition. It can occur as an adverse effect of drugs included in the regiment. Case presentation: This study reported a case of arrhythmia in a 58-year-old male who experienced sudden onset of palpitations, several days after his tuberculosis regiment was changed from the fixed drug combination to a non-hepatotoxic regiment. Based on the clinical presentation, electrocardiogram, laboratory finding, echocardiogram, and analysis of the adverse effects of all given drugs, a drug was suspected as the cause of his arrhythmia. The patient survived after undergoing acute phase management for arrhythmia and discontinuation of the culprit drug. Discussion: One of the serious adverse effects of fluoroquinolone is prolonged QT intervals that could lead to deadly arrhythmia. Therefore, close monitoring of the clinical, vital, and physical is crucial, especially during the first month of therapy. Conclusion: Conscientious consideration should be made before starting therapy for tuberculosis, and acute phase management is pivotal in termination of arrhythmia.
Atina Irani Wira Putri Institut Teknologi Sepuluh Nopember Rizka Nurul Hidayah Institut Teknologi Sepuluh Nopember DOI: https://doi.org/10.12962/j30466865.v2i1.1937 Keywords: Supraventricular
The Potential of Curcuma longa as an Antidiabetic Agent: Review Authors Muhammad Ainur Rosyid Ridho Institut Teknologi Sepuluh Nopember
Hendra GunadiRumah Sakit Umum Pusat Prof. dr. I.G.N.G. Ngoerah Wira GoteraRumah Sakit Umum Pusat Prof. dr. I.G.N.G. Ngoerah DOI:
Yuri Pamungkasa:1:{s:5:”id_ID”;s:35:”Institut Teknologi Sepuluh Nopember”;} Djoko Kuswanto Institut Teknologi Sepuluh Nopember Dwinka Syafira Eljatin Institut Teknologi Sepuluh Nopember Edwin